Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Meeting & Deadlines

2021 Deadlines Heading link

Month Deadline to Submit HGT Protocol* Deadline to Submit Non- HGT Protocol Meeting Date Notify PI By
November October 07, 2021 October 27, 2021 November 11, 2021 November 19, 2021
December November 11, 2021** November 24, 2021 December 09, 2021 December 17, 2021

2022 Deadlines Heading link

Month Deadline to Submit HGT Protocol* Deadline to Submit Non- HGT Protocol Meeting Date Notify PI By
January December 09, 2021** December 09, 2021** January 13, 2022 January 17, 2022
February January 13, 2022 January 26, 2022 February 10, 2022 February 14, 2022
March February 10, 2022 February 23, 2022 March 10, 2022 March 14, 2022
April March 10, 2022 March 30, 2022 April 14, 2022 April 18, 2022
May April 14, 2022 April 27, 2022 May 12, 2022 May 16, 2022
June May 12, 2022 May 25, 2022 June 09, 2022 June 13, 2022
July June 09, 2022 June 29, 2022 July 14, 2022 July 18, 2022
August July 14, 2022 July 27, 2022 August 11, 2022 August 15, 2022
September August 11, 2022 August 24, 2022 September 08, 2022 September 12, 2022
October September 08, 2022 September 28, 2022 October 13, 2022 October 17, 2022
November October 13, 2022 October 26, 2022 November 10, 2022 November 14, 2022
December November 10, 2022 November 22, 2022 December 08, 2022 December 12, 2022

* Any investigator planning to submit a study involving Human Gene Transfer (HGT) or Infectious Agents must contact IBC office prior to submission of the study to discuss study scope and required documentation.  HGT and Infectious Agents used in humans are defined as follows:

1) deliberate transfer of recombinant DNA, or DNA or RNA derived from recombinant DNA into one or more human subjects (in vivo transfer);

2) deliberate transfer of recombinant DNA, or DNA or RNA derived from recombinant DNA into cells that will be transferred into one or more human subjects (ex vivo transfer);

3) deliberate transfer of synthetic nucleic acid molecules, or DNA or RNA derived from synthetic nucleic acid molecules, that meet any one of the following criteria:

  1. a) Contain more than 100 nucleotides; or
  2. b) Possess biological properties that enable integration into the genome (e.g., cis elements involved in integration); or
  3. c) Have the potential to replicate in a cell; or
  4. d) Can be translated or transcribed

4) infectious agents- any agent that is nonrecombinant in nature that is BSL 2 such as some vaccines or toxins.

** Please note that this deadline is earlier than other months due to holiday schedule.

Should you have any questions, please contact the IBC office at oacib@uic.edu